The EMJ Podcast | Episode 165
This week, Jonathan is joined by Mark de Boer, Professor of Infectious Diseases at Leiden University Medical Center (LUMC), the Netherlands, and the current president of the Dutch Working Party on Antibiotic Policy (SWAB). The pair explore the global scale of the “slow pandemic” of antimicrobial resistance, the learning curve of the COVID-19 pandemic, and how we can prepare for future infectious disease management. They also discuss disinformation, the importance of collaboration, and implications for patient care following prosthetic joint infection.
Spotify | Apple | Amazon Music | Download MP3 (27:20 mins)
Speaker bio:
Mark de Boer is Professor of Infectious Diseases at Leiden University Medical Center (LUMC) in the Netherlands, and the current president of the Dutch Working Party on Antibiotic Policy (SWAB).
After receiving his MD in 2001, Mark was trained as a resident in internal medicine at Bronovo Hospital in The Hague, the Netherlands, and Leiden University Medical Center, also in the Netherlands. Subsequently, he enrolled in the infectious disease fellow training programme in Leiden. After registering as an infectious disease specialist, he completed a PhD. His research focus shifted towards the increasing threat of antimicrobial resistance. As senior researcher, he has performed many studies on the understanding and improvement of antimicrobial treatment and stewardship.
In 2017, he was appointed to develop and chair a new national education programme in infectious diseases obligated for residents in internal medicine. Since February 2020, Mark has chaired the Dutch national advice on the medical therapy of COVID-19 for hospitalised patients. Next to his medical specialty, Mark is a qualified clinical epidemiologist. In 2019, he was elected a Fellow of the Infectious Disease Society of America (IDSA). He is a frequently invited lecturer, and has authored over 100 publications in the field of infectious diseases.
